Evidence map›Paper›PMID 25483064›Full record

ArticleCell cycle (Georgetown, Tex.)2014

Oncogenic STRAP functions as a novel negative regulator of E-cadherin and p21(Cip1) by modulating the transcription factor Sp1.

Lin Jin, Pran K Datta

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Lin Jina Division of Hematology and Oncology; Department of Medicine; UAB Comprehensive Cancer Center; University of Alabama at Birmingham ; Birmingham , AL USA.
Pran K Datta
Birmingham VA Medical Center · USPalmetto Hematology Oncology · US

Funding

STRAP and Smad 7 Signaling in Colorectal CarcinomasR01CA095195 · NCI · VANDERBILT UNIVERSITY · PI DATTA, PRAN K · 2003 to 2013
$2.4M
NCI NIH HHS R01 CA095195
6 · The paper itself

Abstract

We have previously reported the identification of a novel WD-domain protein, STRAP that plays a role in maintenance of mesenchymal morphology by regulating E-cadherin and that enhances tumorigenicity partly by downregulating CDK inhibitor p21(Cip1). However, the functional mechanism of regulation of E-cadherin and p21(Cip1) by STRAP is unknown. Here, we have employed STRAP knock out and knockdown cell models (mouse embryonic fibroblast, human cancer cell lines) to show how STRAP downregulates E-cadherin and p21(Cip1) by abrogating the binding of Sp1 to its consensus binding sites. Moreover, ChIP assays suggest that STRAP recruits HDAC1 to Sp1 binding sites in p21(Cip1) promoter. Interestingly, loss of STRAP can stabilize Sp1 by repressing its ubiquitination in G1 phase, resulting in an enhanced expression of p21(Cip1) by >4.5-fold and cell cycle arrest. Using Bioinformatics and Microarray analyses, we have observed that 87% mouse genes downregulated by STRAP have conserved Sp1 binding sites. In NSCLC, the expression levels of STRAP inversely correlated with that of Sp1 (60%). These results suggest a novel mechanism of regulation of E-cadherin and p21(Cip1) by STRAP by modulating Sp1-dependent transcription, and higher expression of STRAP in lung cancer may contribute to downregulation of E-cadherin and p21(Cip1) and to tumor progression.

Indexed as

AnimalsBinding SitesCadherinsCarrier ProteinsCell Cycle CheckpointsCell LineCyclin-Dependent Kinase Inhibitor p21Down-RegulationG1 PhaseHEK293 CellsHeLa CellsHistone Deacetylase 1HumansMicePromoter Regions, GeneticProtein BindingCadherinsCarrier ProteinsCyclin-Dependent Kinase Inhibitor p21HDAC1 protein, humanHistone Deacetylase 1RNA, MessengerSp1 Transcription FactorStrap proteinCDK2, cyclin-dependent kinase 2CDK4, cyclin-dependent kinase 4cell cycleHDAC1, histone deacetylase 1HDAC2, histone deacetylase 2HDAC3, histone deacetylase 3HNF4, hepatocyte nuclear factor 4MEF, mouse embryonic fibroblastNF-YA, nuclear transcription factor Y subunit alphap300/CBP, p300/ CREB-binding proteinPARP, poly (ADP-ribose) polymeraseRhoA, Ras homolog gene family, member ARNase, A ribonuclease ASp1Sp1, specificity protein 1Sp/KLF, specificity protein/Krüppel-like factorSTRAPSTRAP, serine threonine kinase receptor-associated proteinSWI/SNF, SWItch/Sucrose nonfermentabletranscription factorTSA, trichostatin ATSS, transcription start siteTβR I, II, TGF-β receptor I, IIubiquitination

Identifiers

PMID25483064
PMCPMC4614439
OpenAlexW1971618957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.